Specialties
Reports that name this provider
- Psychedelic Treatment Quality in Japan
- Advertises ketamine treatment for inbound international patients with treatment-resistant depression. Started from late 2023. Uses ketamine as an off-label anesthetic rather than an approved psychiatric treatment.